Displaying 48 (all) recruiting clinical trials.
-
A Phase 2a Multicenter Dose Escalation and Dose Optimization Study of SYNC-T Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
This is a Phase 2 study testing a treatment called SYNC-T Therapy SV-102 in adult men with metastatic castration-resistant prostate cancer (mCRPC). SYNC-T Therapy SV-102 ...
-
An Open-label Single-Arm Phase 2 Study to Evaluate Enfortumab Vedotin plus Pembrolizumab for Bladder Preservation in Participants with Muscle-invasive Bladder Cancer
This is a global, open-label, phase 2 study in adult participants with histologically confirmed MIBC (stage cT2–T4aN0M0 or T1-T4aN1M0) who are eligible for RC ... -
A Phase 2 multicenter clinical study to evaluate the efficacy and safety of safusidenib erbumine in patients with isocitrate dehydrogenase 1 (IDH1)-mutant glioma
This is a Phase 2 study testing whether the new drug, safusidenib, is safe and effective in patients with glioma, a type of brain tumor ...
-
A Phase 2 Randomized Blinded Placebo-Controlled Trial Investigating the Efficacy and Safety of Visugromab versus Placebo in Combination with Pembrolizumab Pemetrexed and Carboplatin in First-Line Treatment of Participants with Metastatic Non-Squamous Non-Small Cell Lung Cancer (GDFATHER-NSCLC-01)
This is a Phase 2 study testing a new medicine called Visugromab (also called CTL-002) to see how well it works with standard cancer treatments ...
-
A Phase 2 Multicenter Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants with FGFR3 Altered Low Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer
This study will investigate the safety, tolerability of TYRA-300 and assess different doses of TYRA-300 in participants harboring FGFR3 mutations and/or fusions with intermediate ... -
RADIation after no Axillary Nodal Sampling (RADIANS)
This is a single arm, pilot, prospective study to evaluate the safety of partial breast irradiation in women who undergo breast conserving surgery without SLNB ... -
Safely Optimizing Body Weight with TCMCB07 in Patients with Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy
This is a study testing different doses of a drug called B07 (an experimental drug) to see how it affects body weight, BMI (body mass ...
-
A Phase 2 study to investigate efficacy safety tolerability and pharmacokinetics of JZP3507 (ONC206) in adults with recurrent Grade 2 or 3 Meningioma
This is a Phase 2 study testing a new drug called JZP3507 (an investigational anti-cancer drug) in patients with Grade 2 or Grade 3 meningioma ...